Severe autoimmune hemolytic anemia following rituximab therapy in a patient with a lymphoproliferative disorder

Leukemia and Lymphoma

Volumn 44, Issue 5, 2003, Pages 889-890

  Jourdan, Eric ^a   Topart, D ^a,b   Richard, B ^a,b   Jourdan, J ^a,b   Sotto, A ^a,b  

^a DEPARTMENT OF NEUROLOGY   (France)

^b UNIV MONTPELLIER   (France)

Author keywords

Adverse event; Autoimmune hemolytic anemia; Lymphoproliferative disorder; Rituximab

Indexed keywords

CD20 ANTIGEN; CHIMERIC ANTIBODY; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DOXORUBICIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G1; MONOCLONAL ANTIBODY; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADULT; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CASE REPORT; CAUSE OF DEATH; CHROMOSOME ANALYSIS; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; COOMBS TEST; CYTOKINE RELEASE; DISEASE SEVERITY; DRUG EFFICACY; HUMAN; IMMUNOPHENOTYPING; ISCHEMIC COLITIS; LABORATORY TEST; LYMPHOPROLIFERATIVE DISEASE; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANTIBODIES, MONOCLONAL; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; HUMANS; IMMUNOGLOBULIN M; LEUKEMIA, B-CELL, CHRONIC; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; SPLENOMEGALY;

EID: 0037402501     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/1042819021000055110     Document Type: Article

References (9)

1. Maloney, D.G., Grillo-Lopez, A.J., White, C.A., Bodkin, D., Schilder, R.J., Neidhart, J.A., Janakiraman, N., Foon, K.A., Liles, T.M., Dallaire, B.K., Wey, K., Royston, I., Davis, T. and Levy, R. (1997) "IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma", Blood 90(6), 2188-2195.
2. McLaughlin, P., Grillo-Lopez, A.J., Link, B.K., Levy, R., Czuczman, M.S., Williams, M.E., Heyman, M.R., Bence-Bruckler, I., White, C.A., Cabanillas, F., Jain, V., Ho, A.D., Lister, J., Wey, K., Shen, D. and Dallaire, B.K. (1998) "Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program", Journal of Clinical Oncology 16(8), 2825-2833.
3. Coiffier, B., Haioun, C., Ketterer, N., Engert, A., Tilly, H., Ma, D., Johnson, P., Lister, A., Feuring-Buske, M., Radford, J.A., Capdeville, R., Diehl, V. and Reyes, F. (1998) "Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study", Blood 92(6), 1927-1932.
4. Coiffier, B., Lepage, E., Briere, J., Herbrecht, R., Tilly, H., Bouabdallah, R., Morel, P., Van Den Neste, E., Salles, G., Gaulard, P., Reyes, F., Lederlin, P. and Gisselbrecht, C. (2002) "CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma", New England Journal of Medicine 346(4), 235-242.
5. Zaja, F., Iacona, I., Masolini, P., Russo, D., Sperotto, A., Prosdocimo, S., Patriarca, F., DeVita, S., Regazzi, M., Baccarani, M. and Fanin, R. (2002) "B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia", Haematologica 87(2), 189-195.
6. Matutes, E., Owusu-Ankomah, K., Morilla, R., Garcia Marco, J., Houlihan, A., Que, T.H. and Catovsky, D. (1994) "The immunological profile of B-cell disorders and proposal of scoring system for the diagnosis of CLL", Leukemia 8(10), 1640-1645.
7. Byrd, J.C., White, C.A., Link, B., Lucas, M.S., Velasquez, W.S., Rosenberg, J. and Grillo-Lopez, A.J. (1999) "Rituximab therapy in Waldenstrom's macroglobulinemia: preliminary evidence of clinical activity", Annals of Oncology 10(12), 1525-1527.
8. Weide, R., Heymanns, J. and Koppler, H. (1999) "Induction of complete haematological remission after monotherapy with anti-CD20 monoclonal antibody (RITUXIMAB) in a patient with alkylating agent resistant Waldenstorm's macroglobulinaemia", Leukemia and Lymphoma 36(1-2), 203-206.
9. Dimopoulos, M.A., Zervas, C., Zomas, A., Kiamouris, C., Viniou, N.A., Grigoraki, V., Karkantaris, C., Mitsouli, C., Gika, D., Christakis, J. and Anagnostopoulos, N. (2002) "Treatment of Waldenstrom's Macroglobulinemia with Rituximab", Journal of Clinical Oncology 20(9), 2327-2333.